Ocrelizumab extended dosing in Primary Progressive Multiple Sclerosis during the COVID-19 pandemic: a multicenter experience

被引：0
|
作者：
D'Amico, E. [1 ]
Avolio, C. [1 ]
Lus, G. [2 ]
Bonavita, S. [3 ]
Ferraro, D. [4 ]
Callari, G. [5 ]
Barone, S. [6 ]
Patti, F. [7 ]
Granella, F. [8 ]
Zanghi, A. [9 ]
机构：
[1] Univ Foggia, Foggia, Italy
[2] Univ Campania Luigi Vanvitelli, Naples, Italy
[3] Univ Naples Federico II, Naples, Italy
[4] Univ Modena, Modena, Italy
[5] Irccs Cefalu, Cefalu, Italy
[6] Univ Catanzaro, Catanzaro, Italy
[7] Uni Catania, Catania, Italy
[8] Univ Parma, Parma, Italy
[9] Sant Elia Hosp, Caltanissetta, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1246
引用
下载
收藏
页码：1007 / 1008
页数：2
相关论文
共 50 条
  • [1] Ocrelizumab Extended Interval Dosing in Primary Progressive Multiple Sclerosis: An Italian Experience
    Zanghi, Aurora
    Ferraro, Diana
    Callari, Graziella
    Valentino, Paola
    Granella, Franco
    Patti, Francesco
    Lus, Giacomo
    Bonavita, Simona
    Moretti, Maria Claudia
    Avolio, Carlo
    D'Amico, Emanuele
    CURRENT NEUROPHARMACOLOGY, 2024, 22 (02) : 339 - 345
  • [2] Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19
    Rolfes, Leoni
    Pawlitzki, Marc
    Pfeuffer, Steffen
    Nelke, Christopher
    Lux, Anke
    Pul, Refik
    Kleinschnitz, Christoph
    Kleinschnitz, Konstanze
    Rogall, Rebeca
    Pape, Katrin
    Bittner, Stefan
    Zipp, Frauke
    Warnke, Clemens
    Goereci, Yasemin
    Schroeter, Michael
    Ingwersen, Jens
    Aktas, Orhan
    Klotz, Luisa
    Ruck, Tobias
    Wiendl, Heinz
    Meuth, Sven G.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2021, 8 (05):
  • [3] Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic
    Aurora Zanghì
    Carlo Avolio
    Elisabetta Signoriello
    Gianmarco Abbadessa
    Maria Cellerino
    Diana Ferraro
    Christian Messina
    Stefania Barone
    Graziella Callari
    Elena Tsantes
    Patrizia Sola
    Paola Valentino
    Franco Granella
    Francesco Patti
    Giacomo Lus
    Simona Bonavita
    Matilde Inglese
    Emanuele D’Amico
    Neurotherapeutics, 2022, 19 : 1535 - 1545
  • [4] Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic
    Zanghi, Aurora
    Avolio, Carlo
    Signoriello, Elisabetta
    Abbadessa, Gianmarco
    Cellerino, Maria
    Ferraro, Diana
    Messina, Christian
    Barone, Stefania
    Callari, Graziella
    Tsantes, Elena
    Sola, Patrizia
    Valentino, Paola
    Granella, Franco
    Patti, Francesco
    Lus, Giacomo
    Bonavita, Simona
    Inglese, Matilde
    D'Amico, Emanuele
    NEUROTHERAPEUTICS, 2022, 19 (05) : 1535 - 1545
  • [5] Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic
    van Lierop, Z. Y. G. J.
    Toorop, A.
    van Ballegoij, W. J.
    Dubbelink, T. B. Olde
    Strijbis, E. M.
    de Jong, B. A.
    van Oosten, B. W.
    Moraal, B.
    Teunissen, C. E.
    Uitdehaag, B. M.
    Killestein, J.
    van Kempen, Z. L.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 632 - 633
  • [6] Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic
    van Lierop, Zoe Y. G. J.
    Toorop, Alyssa A.
    van Ballegoij, Wouter J. C.
    Dubbelink, Tom B. G. Olde
    Strijbis, Eva M. M.
    de Jong, Brigit A.
    van Oosten, Bob W.
    Moraal, Bastiaan
    Teunissen, Charlotte E.
    Uitdehaag, Bernard M. J.
    Killestein, Joep
    Kempen, Zoe L. E. van
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (07) : 1121 - 1125
  • [7] Challenges of persons with multiple sclerosis on ocrelizumab treatment during COVID-19 pandemic
    Baba, Cavid
    Yigit, Pinar
    Dastan, Seda
    Hancer, Pelin
    Sagici, Ozge
    Ozakbas, Serkan
    Abasiyanik, Zuhal
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2022, 10 (01): : 3 - 8
  • [8] An Experience of Multiple Sclerosis Telerehabilitation During the COVID-19 Pandemic
    Nora, Monica
    Giannarelli, Michela
    Zicchinella, Cristina
    Mammi, Patrizia
    Ranza, Elena
    Brianti, Rodolfo
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2021, 100 (03) : 214 - 214
  • [9] Extended interval dosing with ocrelizumab in multiple sclerosis
    Novak, Frederik
    Bajwa, Hamza Mahmood
    Ostergaard, Kamilla
    Berg, Jonas Munksgaard
    Madsen, Jonna Skov
    Olsen, Dorte Aalund
    Urbonaviciute, Inga
    Illes, Zsolt
    Stilund, Morten Leif
    Christensen, Jeppe Romme
    Bramow, Stephan
    Sellebjerg, Finn
    Sejbaek, Tobias
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (07) : 847 - 856
  • [10] Brazilian experience in telehealth for multiple sclerosis during the COVID-19 pandemic
    Olival, Guilherme
    Santos, Priscila
    Barbosa, Gisele
    Santos, Gecila
    Telles, Juliana
    Bando, Mauricio
    Dias, Alice
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (02) : NP22 - NP22
12345